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Current orthopedic implants comprised of plastic, ceramic, or metal alloys are 
susceptible to surface degradation at the implant-implant interface. The resulting 
microscopic fragments cause tissue irritation that can lead to osteolysis. In addition, 
existing percutaneous implants, such as pins used to stabilize fractures, are prone to 
bacterial infections due to the inability of the surrounding soft tissue to adhere to the 
implant and form a biologic seal. The goal of this Honors Thesis was to develop porous 
polymeric implants for orthopedic research and development applications that improve 
upon current designs in an attempt to remedy the issues detailed above. A novel approach 
was taken to produce the implants, using an Objet30
®
 Desktop 3D printer to create 
porous structures comprised of open rhombic dodecahedra. The hypothesis of this study 
was that a porous polymeric material will behave much like trabecular bone and allow for 
bone, soft tissue, nerve, and vascular in-growth. Thus, degradation of subcutaneous 
(osseointegrated) implants and infection associated with percutaneous implants would be 
minimized due to increased compatibility with the respective implant site. In addition, the 
use of 3D technology will allow for rapid design and production, thus resulting in a 
quicker and more economical research and development process. A cell culture 
experiment was performed by seeding implants with Buffalo Rat Liver cells. The results 
of this experiment showed that the polymeric material used was cytotoxic, with almost no 
cell attachment. To test the effectiveness of the porous implants in vivo, both 
subcutaneous and percutaneous implants were placed on the dorsa of six New Zealand 
White rabbits. The results of this project demonstrated the ability to achieve tissue in-
 
 
growth and vascularization of both subcutaneous and percutaneous implants with a 
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 In recent years the need for improved and more affordable healthcare has been at 
the forefront of both government policy agenda and scientific research and development. 
As the Baby Boomer generation gets older, a greater percentage of the U.S. population is 
becoming dependent upon healthcare services. With such people reaching an age where 
they are covered under government healthcare programs, a strain is being placed on state 
and federal budgets. Healthcare costs themselves are increasing as well due to high-tech 
procedures and rising insurance premiums; approximately $2.7 trillion was spent on 
healthcare in the U.S. in 2011 and this figure is expected to increase to $3.6 trillion in 
2016.
1
 An aging population, combined with widespread health issues such as obesity, 
brings about a need for improved healthcare. This need has resulted in substantial 





 The orthopedic industry, which is of primary concern to this thesis, is an 
important sector of the healthcare industry that demonstrates an annual growth of 5-7% 
on a global scale.
3
 The American Academy of Orthopedic Surgeons reports that each year 
approximately 28.6 million Americans incur some manner of musculoskeletal injury.
4
 In 
order to repair these injuries medical device and equipment manufacturers have 
developed products ranging from artificial joints and fixations for stabilizing fractures to 
products that replace or stimulate the growth of bone. In the year 2012 it is expected that 
2 
 
the U.S. market for orthopedic products will reach $14.2 billion.
4
 Products that are 
common for elderly patients who suffer from osteoarthritis are artificial hips and knees. 
In 2009, the sale of artificial hips and knees reached $6.7 billion in the U.S., with these 
artificial joints selling for $3,000 to $15,000 a piece.
5
 In addition to the treatment of 
musculoskeletal degeneration, trauma treatment is a critical aspect of orthopedic 
medicine, with the global market for trauma devices expected to reach $4.8 billion in 
2012.
6
 Trauma devices can be divided into two categories, internal fixation devices such 
as plates and screws, and external fixation devices such as pins and frames. External 
fixation, which is an important methodology that is addressed in this thesis, is expected to 
result in device sales of $203 million in 2012.
6  
 
Traditional Implant Design and Fabrication 
 The history of orthopedic implants dates to the 1880s when metal plates and 
screws were first used for internal fixation.
7
 In the 1950s, a Russian by the name of 
Gavril Abramovich Ilizarov pioneered the use of external fixation as a means of repairing 
fractures. Ilizarov’s design for an external fixation apparatus is still in use today.
7 
The 
1960s brought about the first total joint replacement when Sir John Charnley of England 
discovered that the surfaces of the hip joint could be substituted with metal or high 
density polyethylene which were cemented in place.
7
 Using similar materials and 
methods as the first total hip replacement, David L. MacIntosh developed the total knee 






 Since the conception of these initial implants alterations and improvements have 
been made to the materials of construction (MOC), with joint surface (implant-implant 
interface) integrity being of utmost importance to internal implants. Current internal 
implants are comprised of materials such as titanium, cobalt-chromium-alloy, and high-
density polyethylene. In most instances metal implants are highly polished in order to 
prevent wear on the surrounding bone and to avoid breakdown of the implant itself. 
Polyethylene is used as an MOC as its smooth surface is also thought to prevent these 
issues. Although degradation of implant stems and screws are of concern, the breakdown 
of the bearing surfaces of artificial joints is the major issue with internal orthopedic 
implants. In the United States alone, there are over 1 million hip and knee replacements 
performed each year.
8
 These replacements typically have a success rate of ~90% over a 
ten year period, with aseptic loosening being the major complication and reason for 
revision.
9
 Aseptic loosening, which is the loosening of implant components in the 
absence of infection, is believed to be caused primarily by small fragments of implant 
material known as wear particles. It has been recently discovered that the majority of 
wear particles, which result from implants made from metals, ceramics, and 
polyethylene, are submicroscopic and can be as small 10nm or less in length.
9
 The small 
size of these wear particles allows them to easily spread to different areas of the joint, 
such as the bone-implant interface, where they can then cause inflammation and 
osteolysis.   
 
 Percutaneous implants used in external fixation are comprised of similar MOC as 
internal implants, with most pins made out of stainless steel or titanium. Pins traditionally 
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have smooth surfaces and are terminally threaded to allow them to be screwed into the 
bone. In order to stabilize the fracture, the exposed portions of the pins are then attached 
to an external fixator which consists of metal rods that can be tightened or adjusted. 
Compared to the use of internal plates and nails, external fixation causes less soft tissue 
trauma and allows for more precise alignment and improved stability. Percutaneous pins 
may also be coated with the calcium-phosphate mineral hydroxyapatite (HA). 
Hydroxyapatite has been shown to promote bone growth, and in the case of percutaneous 
pins it is effective in decreasing infection rates and preventing pins from loosening.
10
 
Despite advancements in percutaneous implant designs and procedures, infection as a 
result of external fixation is still quite common. The percentage of deep infections 
observed in patients with external fixation devices is approximately 16.4% overall 
(almost 1 out of every 6 patients), with chronic osteomyelitis (bone infection) occurring 




 A majority of the orthopedic implants that are currently on the market are 
manufactured by traditional methods such as machining, molding, or compression. Metal 
implants are typically machined or forged, and polyethylene implants are constructed 
from polyethylene powder through various consolidation methods (e.g. ram extrusion).
12
 
Post-fabrication modifications can be made to implants as well, such as nitriding which 
produces a hard surface of titanium nitride, and ion implantation which increases the 
implants resistance to wear.
12
 In addition to these common manufacturing processes, 
technological advancements have led to fabrication methods that are faster and more 
precise. Of particular interest is the method of electron beam melting (EBM) which 
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employs an electron beam to melt metallic powders under vacuum to produce three 
dimensional (3D) structures. EBM can produce solid structures that have the mechanical 
properties required for orthopedic implants. The Swedish company Arcam™ developed 
the technology of EBM and the concept of selective laser melting. Arcam™ EBM 
machines allow users to develop implant designs using computer-aided design (CAD) 
programs and then have the implants constructed in a matter of hours.
13
 There are 
currently several medical device manufacturers using Arcam™ EBM technology to 
produce orthopedic implants that are European Conformity (CE)-certified and Food and 




 The current methods of orthopedic research and development (R&D) are often 
costly and time intensive. Material costs can range from $6-$7/lb for cast titanium to 
$41/lb for forged cobalt chrome (1992 world commodity prices).
14
 Developing a new 
implant involves designing and testing several iterations, and using materials such as 
titanium or cobalt chrome for prototype development can dramatically increase overall 
development costs. Another major contributor to the cost of designing an implant is the 
manufacturing process, with a forged cobalt-chrome primary hip costing between $80 
and $125/piece to manufacture and a cast titanium component costing between $100 and 
$150/piece to manufacture.
14
 Due to its curved shape, the manufacturing of a tibial 
condyle to be used in knee replacements can take upwards of 30 hours. Similarly, the 
time it takes to machine and finish a total hip implant can be in excess of 20 hours.
14
 
Given the considerable amount of time between implant design and production, implant 
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R&D can be a lengthy process. In total, the R&D costs of a new orthopedic implant can 
be on the order of $50 million.
15 
The manufacturing of implants through the use of EBM 
technology mentioned above helps to reduce R&D (and product) costs. Arcam™’s 
estimated manufacturing cost is $144/ machine hour, which includes operator and 
material costs and additional expenses.
16
 Using an Arcam™ EBM machine, a hip implant 
can be manufactured for approximately $260 in a fraction of the time it takes to produce 
the same implant by traditional methods.
16
 In terms of economics, the downside of EBM 
machines is their considerable upfront cost which in many cases render them 
impractical/uneconomical as a means of manufacturing (or for use in research 




The use of porous materials/structures for internal orthopedic implants is quite 
common. Porous implants were initially developed in order to achieve osseointegration 
and attachment of the implant without the use of cement, which was thought to a source 
of wear particles. Porous implants are able to achieve osseointegration and soft tissue in-
growth; however, issues with wear particles are still present. The most common porous 
structures that are used are titanium plasma spray coatings and cobalt-chromium-alloy 
fiber metal mesh.
18
 Despite the relatively low porosities of titanium plasma spray 
coatings and cobalt-chromium-alloy fiber metal mesh (20-30% and 40-50%, respectively) 
these conventional porous materials have been proven capable of facilitating bone in-
growth.
18 
 In addition to porous coatings, fully porous implants exist that seek to imitate 
the trabecular structure of cancellous (spongy) bone. Trabecular implants are typically 
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made using vapor deposition of tantalum metal. With a porosity of 80.9% and an elastic 
modulus closer to that of bone tissue, trabecular implants composed of tantalum metal 
demonstrate greater biocompatibility with bone than implants with porous coatings.
 18 
Implants with manufacturer-defined trabecular structure can also be made using CAD 




In terms of percutaneous implants, research has been performed investigating 
means to prevent infections in external orthopedic fixations. Special surface modification 
using diamond-like carbon coatings to prevent bacterial adhesion and bio-film formation 
has been performed.
20
 At this point in time, porous material/design is not used 
commercially for percutaneous implant applications. However, the idea of using soft 
tissue in-growth facilitated by porous structures to create a biologic seal has been 
researched for many years. The studies performed on this subject have had mixed 
success. In one study, porous button shaped implants (subcutaneous disk and 
percutaneous post) were made by sintering HA powder and polyurethane beads.
21
 All of 
the implants, which were placed through the dorsal skin of adult mongrel dogs, fell out or 
had to be removed 1 month post implantation due to severe bacterial infection.
21 
Another 
recent study, which used porous coated (~400μm pore size) titanium implants, was 
performed to analyze the potential of developing osseointegrated percutaneous implants 
for amputee prosthetics.
22
 These porous implants (subcutaneous disk and percutaneous 
post), which were implanted in New Zealand White rabbits, showed a 7-fold decreased 
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risk of infection compared to similar smooth implants after being inoculated with 
Staphylococcus aureus  while in vivo.22 
 
Implant Application of 3D Printing 
 As with any industry, the ability to cheaply and rapidly design and produce 
prototypes of new products results in more efficient and economical orthopedic implant 
R&D. Quick and economical prototyping can be accomplished through a process known 
as rapid prototyping. As the name suggests, rapid prototyping methods are faster than 
traditional fabrication techniques and allow for more precision and control with CAD 
software used to design the object that is to be made. 3D printing is an additive method of 
rapid prototyping that creates 3D objects by layering material in the shape/profile defined 
by a 3D computer model. Selective laser sintering (SLS), selective laser melting (SLM), 
electron beam melting (EBM), and fused deposition modeling (FDM) are all types of 3D 
printing. As mentioned above, FDA approved implants (porous and non-porous) have 
been made utilizing 3D printing through the use of Arcam™ EBM machines. SLM 3D 
printing gained attention recently when it was used to create a tailor-made titanium 
jawbone for an elderly patient suffering from osteomyelitis.
23
 As for 3D printing of non-
metallic implants, this appears to be an area of very little development. A study was 
performed to develop porous ceramic scaffolding for bone tissue engineering applications 
using a specialized 3D printer; however, the manufacturing process also involved a 
sintering step which in turn caused shrinkage of the scaffold bodies.
24
 Despite the field of 





 released a rigid plastic-like biocompatible material approved 
for skin or mucosal-membrane contact.
25
 Although this material is not specifically 
designed/ approved for internal implantation, it signifies the potential ability to integrate 
3D printing in the production of medical devices (i.e. orthopedic implants). In addition, 
the development of biocompatible polymeric materials that can be 3D printed allows for 
this technology to be used as an economical means of R&D for in vivo testing of implant 
prototypes. 
Objective 
Given the performance characteristics and production costs of current orthopedic 
implants, in addition to the significant need for these implants, it is evident that there is 
meaningful work that can be performed in the development of novel materials and 
fabrication processes. The objective of this study was to develop a porous polymeric 
implant, using 3D printing technology, which facilitates soft tissue in-growth for use in 
orthopedic R&D testing of subcutaneous and percutaneous implants. For internal 
implantation the porous structure should allow for soft tissue in-growth and 
osseointegration, both of which will aid biocompatibility and improve the implant’s 
intended function. For percutaneous implantation the pores will allow for soft tissue in-
growth which will form a biologic seal between the implant and dermal layer, thus 
preventing bacterial infection. Polymer, as opposed to metal, was chosen as the material 
of construction as only low levels of porosity are achievable with porous metallic 
materials (with the exception of tantalum). In addition, due to the structural 
characteristics of porous metals they can only be used as implant coatings.
18
 The elastic 
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moduli of cobalt-chromium and titanium alloys are 210 GPa and 110 GPa, respectively; 
whereas the elastic modulus of bone ranges from 0.1-18 GPa.
18
 It is critical that an 
implant has a similar elastic modulus to that of bone in order for osseointegration to 
occur. Given these structural discrepancies, current porous metallic materials are 
deficient in terms of biocompatibility and long term reliability. It is noted that porous 
tantalum materials have been developed that improve biocompatibility and mechanical 
properties; however, the costs associated with materials and construction are major 
disadvantages of implants comprised of tantalum. 3D printing was selected as the method 
of fabrication for several reasons. First, rapid prototyping/manufacturing 3D printing 
allows for iterations of implant designs to be quickly modeled and manufactured. 3D 
printing also allows complete control over implant design, such as overall shape and 
component dimensions (i.e. pore size). Lastly, 3D printing offers a more economical 
method of performing orthopedic implant R&D, as manufacturing and labor costs as well 
as material costs (in this case a polymer) are lower than those of traditional methods. 




 With the decision made to produce the porous polymer implants through the use 
of 3D printing technology, a 3D printer capable of rendering porous structures was 
required. The printer selected was an Objet30
®
 Desktop 3D printer located at the 
Manufacturing Applications Center (MAC) at the University of Southern Maine, 
Gorham, Maine. The Objet30
®
 Desktop works by printing 16-micron-thick layers of a 
photopolymer material in both the horizontal and vertical direction until the 3D structure 
11 
 
is complete. After each layer is printed, UV light is used to cure the material. In order to 
support the structure while it is being printed a gel-like support material is laid down 
simultaneously, and is later removed by either a physical or chemical process. Structures 
as thin as 28-microns can be printed, with an accuracy of 0.1mm (see Appendix A for 
complete technical specifications). The retail price of the Objet30
®
 Desktop printer at 
MAC at the University of Southern Maine was approximately $48,000. 
Implant Material 
 In order to fully evaluate the feasibility of using 3D printing to generate effective 
porous implants, an in vivo small animal trial was performed. As such, the implant 
material required the mechanical strength to withstand animal movement, material 
properties to withstand both sterilization and in vivo physiological conditions 
(temperature, pH, etc.), and be biocompatible in vivo. With the Objet30
®
 Desktop printer 
selected for production of the implants, the material options were limited to those that 
could be printed by this specific printer. Of the materials capable of being printed, Vero 
White Plus Fullcure 835 was selected for its material and mechanical properties as a 
polypropylene-like plastic (see Appendix B for complete technical specifications). 
Material Testing 
 To test the effects of temperature on Vero White Plus Fullcure 835, samples of 
the material (2.5cm diameter, 5mm thick discs) were placed in a water bath for 30min at 
40
o
C to simulate the internal temperature of a rabbit.
26 
In addition, samples of Vero 
White Plus Fullcure 835 were exposed to the following solutions for 30min: 70% ethanol, 
12 
 
7.5% hydrogen peroxide. Samples of Vero White Plus Fullcure 835 were also exposed to 
0.9% saline in water for a period of one week. 
Implant Design 
 In order to evaluate the performance of 3D printer generated porous polymer 
implants in both subcutaneous and percutaneous applications two implant designs were 
developed.  
For the evaluation of subcutaneous applications a simple rectangular block design 
was developed. In order to allow for direct comparison of results with a previous small 
animal trial using rectangular blocks of alumina ceramic, the dimensions were set at 
30mm long, 20mm wide, and 6mm thick. The blocks also included a 2mm diameter 
suture hole in each of the four corners to allow for the blocks to be anchored to the 
subcutaneous tissue. Figure 1 presents the basic block design developed using the 3D 










With the basic block design in place, attention was turned to development of the 
porous structure of which the block would be comprised. As the blocks were to be printed 
by an Objet printer, the program employed to design the porous structure was required to 
produce a computer-aided design (CAD) file that can read by Objet printers. With 
assistance from engineers at the Advanced Manufacturing Center (AMC) at the 
University of Maine, Orono, Maine the porous block design (and all other implant 
designs) was developed using the SolidWorks 3D CAD software package. In developing 
a porous structure, or matrix, using SolidWorks several limitations were encountered. 
Given the computational demands of creating 3D objects in SolidWorks, and the complex 
nature of a porous structure, the design was limited by the file size that the computer 
could process and that the Objet printer could produce. Congruently, a random porous 
design that would require the pores be individually drawn by hand was forgone in favor 
of a patterned design of identical pores that required less design work and resulted in a 
smaller overall file. As such, a patterned design was developed that attempted to imitate 
trabecular bone. The patterned design was comprised of rhombic dodecahedrons which 
have 12 open rhombic faces, 24 edges (struts), and 14 vertices. Rhombic dodecahedra 
were used in order to create a complete space filling matrix. The rhombic dodecahedra 
were placed side-by-side in rows and then stacked on top of each other. Figure 2 presents 
a matrix of rhombic dodecahedra in two rows. Figure 3 presents a computer simulated 

























Figure 3: Trabecular bone structure in human vertebrae. Courtesy of Berkeley Lab. 
 
  
With the pore design determined, attention was turned to the pore dimensions. 
Similar small animal trials performed at the University of Maine using porous titanium 
and alumina ceramic implants determined that tissue attachment may occur over a range 
of pore sizes. However, the pore size of trabecular bone is typically defined as 500-600 
microns.
28
 The second pore dimension, strut thickness, is more varied than pore size (see 
Figure 3 above). However, the strut thickness for other manufactured porous implants 
15 
 
seeking to imitate trabecular bone (e.g. Trabecular Metal™ made from tantalum metal) is 
of the order of 100-150 microns.
18 
With the capability to easily change dimensions in 
SolidWorks and rapidly print new implant designs, rectangular block implants were 
printed with several different pore dimensions. Blocks were printed with both 400 and 
800 micron (approx.) internal pore diameters and a strut thickness of 76 microns 
(approx.). A third iteration of the block design set the internal pore diameter to 564 
microns (approx.), and increased the strut thickness to 152 microns (approx). In addition 
solid polymer reinforcements were added to the inside of the suture holes and along the 
outer edges of the block. A fourth iteration of the block design set the internal pore 
diameter to 1200 microns (approx.), increased the strut thickness to 280 microns 
(approx), and employed the same solid polymer reinforcements of the third design. It 
should be noted that the 400 micron dodecahedron blocks were mistakenly printed at an 
increased thickness, which was most likely due to a dimensional error in the SolidWorks 
file. Images of the 400 and 800 micron dodecahedron blocks are presented in Figures 4 
and 5, respectively. The 1200 micron dodecahedron block with reinforcements is shown 
in Figure 6. Figure 7 presents the SolidWorks design of the 1200 micron dodecahedron 





























































Figure 7: 1200 micron dodecahedron block SolidWorks design. 
 
 
For the evaluation of percutaneous applications a button design was developed 
that was modeled after a tuxedo stud. The button design consisted of a circular base, post, 
and domed cap made out solid polymer. The base and post were covered with 
approximately 3mm of porous matrix. The concept behind the design was that, once 
implanted, the base of the button would sit on top of the subcutaneous tissue, the post 
would pass through the dermal layers, and the cap would sit on top of the skin. The 
porous matrix covering the base and post would allow for tissue in-growth, while the 
solid plastic cap would aid in keeping the implant in position and prevent skin growth 
over the implant. The porous matrix employed to cover the base and post uses the same 
18 
 
design as the porous matrix employed for the blocks. Figure 8 presents the initial button 










Figure 8: Button design developed using Google SketchUp 8 
 
 With the button design set, SolidWorks was utilized to develop three different 
porous button designs. The first set of buttons that were printed had a pore size of 400 
microns (approx.) and a strut thickness of 76 microns (approx.). The second set of 
buttons that were printed had a pore size of 564 microns (approx.) and a strut thickness of 
152 microns (approx.). The third set of buttons that were printed had a pore size of 1200 
microns (approx.) and a strut thickness of 280 microns (approx.). In order to provide 
enhanced rigidity and durability, the porous matrix of both the second and third designs 
included a cage of solid polymer along the exposed edges. Figures 9 and 10 present side 
views of the first and second button designs created in SolidWorks, respectively. Figure 
19 
 
11 presents the third button design in SolidWorks, and an image of the printed product is 
given in Figure 12. The SolidWorks designs and images of the printed products of the 





































































































Figure 13: 564 micron dodecahedron button (left) vs. 1200 micron dodecahedron button 

















Figure 14: 564 micron dodecahedron button (left) vs. 1200 micron dodecahedron button 




It is evident from examination of Figures 13 and 14 that a difference in the shape 
of the base exists between the two implant designs. Since the pores have flat sides and 
sharp vertices the base cannot be made to be perfectly circular. As the pore size increased 
the design of the base was modified to connect the number of exposed vertices by 
employing lines, rather than circular edges. It is noted that all block and button images 
were taken after the removal of the support material. The support material was removed 
by immersing the implants in a 2% NaOH aqueous solution. The implants were immersed 
for a time approximately three days, with the solution changed daily. Figure 15 presents 
images of an 800 micron dodecahedron block and a 400 micron dodecahedron button 







Figure 15: 800 micron dodecahedron block and 400 micron dodecahedron button prior to 
removal of support material. 
  
Cell Culture 
 In addition to performing a small animal trial to evaluate in vivo performance of 
the implants, cell culture experiment were undertaken in order to assess basic cell 
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attachment, and to assess potential cytotoxicity of the implant material (Vero White Plus 
Fullcure 835). Buffalo Rat Liver cells (BRL 3A) from ATCC™ were selected due to their 
adherent growth properties and relative ease of culturing. After propagating the BRL 
cells and culturing them to confluency, the cells were re-suspended and seeded on a 
variety of the different porous plastic designs. For comparative purposes, the cells were 
also seeded on tantalum foam plugs and a porous alumina ceramic block. To examine 
potential cytotoxicity of the support material employed during printing, cells were seeded 
on samples of support material. The detailed cell culture protocol is given in Appendix D. 
It should be noted that prior to the cell culture experiment took place, a sterilization test 
was performed in order to determine the effectiveness of sterilizing the implants by 
means of a liquid sterilization process (see Appendix C). The objects seeded in the cell 
culture experiment were either sterilized by the liquid process described in Appendix C, 
or via ethylene oxide at Eastern Maine Medical Center, Bangor, Maine. The objects that 
were seeded in the cell culture experiment, and the means by which they were sterilized, 
are detailed in the results section. 
 
Implantation 
 Given that the objective of the study was to evaluate the performance of porous 
polymer implants in facilitating soft tissue in-growth, the most practical and 
representative means of assessment was to perform an in vivo small animal trial. Upon 
receiving approval from the Institutional Animal Care and Use Committee (IACUC) of 
the University of Maine, Orono to perform a small animal trial, six New Zealand White 
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strain rabbits (Oryctolagus cuniculus) each weighing 4-4.5 kg were obtained. The rabbits 
were given sufficient time to acclimate to the Small Animal Research Facility (SARF) at 
the University of Maine, Orono and were subjected to thorough physical examinations by 
the institutional veterinarian, Dr. James Weber. 
Prior to implantation, a simple allergy test was performed on the rabbits in order 
to determine whether general skin contact with the implant material would illicit an 
immune response. The allergy test involved taping plastic discs (2.5cm diameter and 
5mm thick) to the inside portion of the rabbit’s ear with medical grade tape. The discs 
remained in place for several days before the ear was examined for signs of irritation. 
 To allow for sufficient spacing of implants, and to minimize animal manipulation, 
the subcutaneous and percutaneous implants were placed along the dorsum of the rabbits, 
on either side of the spine. Given the high risk of infection associated with percutaneous 
implants, the rabbits received either all subcutaneous implants, or all percutaneous 
implants; so as not to risk losing successful implants as a result of unsuccessful implants 
of a different design. Surgical procedures were performed by Dr. Ian Dickey, an IACUC 
approved, licensed orthopedic surgeon in the surgery suite of the SARF. Operations were 
performed under general anesthesia, with each rabbit receiving four implants. The 
implants were anchored to the subcutaneous tissue with absorbable sutures, and the 
incisions were closed with subcuticular sutures. Each rabbit was given both non-steroidal 
anti-inflammatory agents as well as anesthetics for pain management. The rabbits were 
closely observed post-operation to ensure their comfort and return to normal activity 
patterns and feeding behavior. Section 7c. of Appendix E (IACUC Protocol Review 
Form) provides a complete description of the surgical procedures. In order to allow 
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sufficient time for soft tissue in-growth it was decided that six weeks would be given 
between the time of implantation and removal of implants, with any signs of infection or 




 For the removal of the subcutaneous implants a single incision through the skin 
was made down the dorsal midline and the four implants (two on either side of spine) 
were harvested en bloc with their surrounding soft tissue. For the removal of the 
percutaneous implants four incisions through the skin were made around each implant, 
thus harvesting the implants in square sections of dermal tissue. After performing a gross 
anatomical analysis, the implants were placed in containers of formalin for preservation 
until histologic examination was performed.  
 Histologic examination commenced with cutting of the harvested implants into 
cross-sections to reveal the interior of the implants, and thereby enable evaluation of the 
degree of tissue in-growth. Subsequently, the tissue plus implant cross-sections were 
processed and embedded in paraffin. The paraffin blocks were sectioned into ribbons 
using a Leica RM2155 Microtome. The resulting ribbons of tissue plus implant were 
mounted on glass slides and stained with hematoxylin and eosin (H&E) which stains 
nuclei blue and stains other cellular structures shades of pink or red. The slides were 
subsequently examined under a microscope for determination of cell formation and 
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neovascularization, and to assess if inflammation or cell death had occurred. Appendices 
F-H detail the procedural aspects of the histological processes.   
 
  
RESULTS AND DISCUSSION 
Material Testing 
 Equilibrating the Vero White Plus Fullcure 835 samples at 40
o
C in water resulted 
in a slight increase in pliancy. However, this effect was not permanent and the samples 
regained their normal levels of rigidity soon after removal from the water bath. 
 Exposing Vero White Plus Fullcure 835 samples to 7.5% hydrogen peroxide, and 
seperably 70% ethanol, was undertaken to determine if these chemicals could be used as 
sterilants (see Appendix C) without degrading the implants. Neither of these treatments 
resulted in obvious degradation of the plastic, or altering of its mechanical properties. 
 Equilibrating Vero White Plus Fullcure 835 samples with 0.9% saline solution 
was performed to evaluate the materials ability to withstand in vivo ionic conditions; no 




 As detailed in the Materials and Methods Section, a series of design iterations 
were developed for both the subcutaneous and percutaneous implants. The iterations 
occurred due to the desire to as closely possible mimic the structure of human trabecular 
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bone. Pre-operative analysis of all implant designs was performed by the project team in 
order to gauge potential for success and to avoid heedless use of animal subjects. The 
pre-operative analysis involved visual evaluation of the pore size and structure, the 
overall implant design, and determination of the extent of scaffolding material removal. 
The pre-operative analysis led to several design iterations prior to implantation.  
As stated in the Implant Design portion of the Materials and Methods Section, 
typical pore dimensions for human trabecular bone are known. These dimensions were 
used as a guide for the design of the first generation of porous implants. However, visual 
inspection of the printed implants revealed a discrepancy between the pore size of 
trabecular bone and the pore size of the printed implants, with the pore size of the printed 
implants being considerably smaller. The primary reason for the discrepancy is believed 
to be a miscommunication during the design process, specifically, the internal diameter of 
the rhombic dodecahedra were set to mimic the internal pore diameter of trabecular bone. 
Comparison of Figures 2 and 3 reveals that many of the pore openings of human 
trabecular bone are close in size to its internal pore diameter, whereas with the rhombic 
dodecahedron design the pore openings (rhombic faces) are significantly smaller than its 
internal pore diameter. Since the pore openings serve as passages for tissue in-growth it is 
presumably critical that the size of the pore opening size be physiologically accurate. In 
addition, it is noted that the actual dimensions printed may not accurately reflect the 
design dimensions. With the dimensional issues encountered, appropriate changes were 
made to the implant design, resulting in several iterations of blocks and buttons with 
increasing internal pore diameter. Although the material testing did not show material 
degradation for any condition, pre-operative inspection of liquid sterilized 400 micron 
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and 800 micron implants (block and button design) showed breakdown of the porous 
matrix and softening of the overall structure. These observations were believed to be a 
result of the minimal strut thickness employed and rocking during sterilization, rather 
than chemical degradation of the material. As such, with the pore size increase to 564 
microns the strut thickness was also increased and a protective cage was added. A 
wicking test with methylene blue was performed on a 564 micron button to test porosity. 
This test showed very little wicking of the methylene blue into the button. As the 
methylene blue test indicated inadequate porosity with 564 micron pores, blocks and 
buttons were designed with 1200 micron pores, increased strut thickness, and a protective 
cage (see Figures 7 and 11). Appendix I contains a complete set of design drawings 














 The layout of the cell culture experiment is provided in Table 1. 
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 The experiment consisted of two trials; the Petri dish and plates 1-3 in Trial #1, 
and plates 4-9 in Trial #2. 
 For Trial #1 all objects were sterilized using the process described in Appendix C. 
After 24hr incubation with BRL cells, the results of Trial #1 were as follows. The 
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implants in the Petri dish had 0% attachment, and complete cell death. In plates 1-3 of 
Trial #1, a majority of the wells demonstrated 0% attachment (to the object or well itself) 
and complete cell death. Several of the solid objects (wells 5-8 of plates 1+2 and wells 
5+6 of plate 3) demonstrated low levels of attachment (20-30%), while the control well in 
plate 3 had ~75% attachment. 
 For Trial #2 all objects were sterilized using the process described in Appendix C 
except for the block in well #1 of plate 7, the buttons in plate 5, and the objects in plate 2; 
these objects were ethylene oxide sterilized according to standard hospital procedures. 
The alumina ceramic block and small tantalum foam plugs of plate 2 demonstrated no 
signs of cytotoxicity and possessed confluent cell growth. The scaffold material samples 
had no cell adhesion, but did not demonstrate cytotoxicity. All other objects cultured in 
Trial #2 demonstrated levels of cytotoxicity and little to no cell attachment.  
 Given the results of the cell culture trials, several conclusions can be made. The 
levels of cell growth and attachment on the control wells, and on the alumina ceramic 
block and tantalum foam plugs lead to the conclusion that the BRL cells were 
successfully cultured. This conclusion, combined with the cytotoxicity and low levels of 
attachment observed with the 3D printed implants, suggests that the 3D printed implants 
were cytotoxic. Culturing on the scaffold material samples did not indicate that the 
scaffold material were cytotoxic (however, no visible cell attachment occurred). 





 The first of two sets of surgical implantations occurred on March 19, 2012 and 
consisted of subcutaneous implantation in two rabbits (designated as Rabbit #1 and 
Rabbit #2). The two rabbits each received two 800 micron dodecahedron blocks, with the 
blocks placed cranially on either side of the spine. In addition, the two rabbits received 
two 400 micron dodecahedron blocks, with the blocks placed caudally on either side of 
the spine.  
 The second set of surgical implantations occurred on April 20, 2012 and consisted 
of subcutaneous implantation in one rabbit (designated as Rabbit #3) and percutaneous 
implantation in a separate rabbit (designated as Rabbit #4). Rabbit #3 received four 1200 
micron dodecahedron blocks, two placed cranially on either side of the spine and two 
placed caudally on either side of the spine. Rabbit #4 received four 1200 micron 
dodecahedron buttons, two placed cranially on either side of the spine and two placed 
caudally on either side of the spine (individual incisions made for each implant). The 
procedures for both the subcutaneous and percutaneous implantations are provided in 
Section 7c. of Appendix E (IACUC Protocol Review Form). 
 The results of the cell culture experiment indicating that the polymer employed to 
construct the implants was toxic to BRL cells were obtained in the second week of April 
2012. As such, it was decided that the implants in Rabbit #1 would be harvested ahead of 
schedule to determine if the cell culture results translated to in vivo results. It is noted 
that during the weeks following implantation, Rabbit #1 demonstrated normal levels of 
activity and typical feeding behavior, with no signs of distress evident. Rabbit #1 was 
sacrificed April 20, 2012 (see section 7a. of Appendix E (IACUC Protocol Review Form) 
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for the euthanization procedure). The implants were harvested as described in the 
Materials and Methods Section. During removal of the implants, a gross anatomical 
analysis of the rabbit did not reveal any abnormalities. A complete necropsy of the rabbit 
post implant removal indicated that the animal was in good health. Neither of the 400 
micron dodecahedron blocks removed from Rabbit #1 demonstrated substantial 
attachment of the surrounding tissue. Instead, the formation of interstitial pockets 
surrounding the implants was observed (see Figure 16). This result may be due to either 
the small pore size of the blocks or the cytotoxic nature of the implant material. 
Conversely, both the 800 micron dodecahedron blocks removed from Rabbit #1 
demonstrated considerable tissue attachment as well as what appeared to be complete soft 





















Figure 17: Removal of an 800 micron dodecahedron block from Rabbit #1. 
 
Upon review of the partially successful in-growth results of Rabbit #1, the 
decision was made that Rabbit #2 would be given the full six week trial period before 
implant removal. Rabbit #2 was sacrificed May 11, 2012, and the implants were 
harvested as described in the Materials and Methods Section. The results of implant 
removal from Rabbit #2 were essentially the same as those of Rabbit #1, with the 400 
micron dodecahedron blocks resulting in pocket formation rather than tissue attachment 
(see Figure 18), and the 800 micron dodecahedron blocks demonstrating excellent soft 























Figure 19: Removal of an 800 micron dodecahedron block from Rabbit #2. 
 
 In addition to removing the implants from Rabbit #2, Rabbit #3 was also 
sacrificed May 11, 2012. The decision derived from the apparent success of soft tissue in-
growth in the larger pore size in rabbits #1 and #2, suggesting that substantial tissue in-
growth into the 1200 micron dodecahedron blocks of Rabbit #3 may have been achieved 
in a shorter amount of time. In addition, with knowledge that the implant material was 
cytotoxic, it was decided that it was best to remove the implants as soon as possible. 
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Indeed, the 1200 micron dodecahedron blocks demonstrated a very high level of both 
tissue attachment and soft tissue in-growth (Figures 20 and 21). The cranially placed 
implants showed a small amount irritation of the subcutaneous tissue in the region of 
placement, a fact attributed to the anatomical locations of these implants and tissue 



























 Rabbit #4, with the percutaneous implants, was closely monitored post-operation 
due to the increased inherent increased potential for infection. However, after receiving 
NSAIDs and anesthetics for only two days post-operation, and antibiotics for only three 
days post-operation, considerable healing was evident around the post of the implants. 
Indeed, the skin layer was well-apposed to the post and no signs of infection were evident 









Figure 22: Percutaneous implant wound closure 24 hours post implantation. 
 
 
 Rabbit #4 was sacrificed on May 11, 2012 (for the same reasons as Rabbit #3), 
and the percutaneous implants harvested en bloc as described in the Materials and 
Methods Section. It is noted the caps of three of the four buttons implanted into Rabbit #4 
had been broken off through action of the rabbit, with the caps broken off on May 5, 6, 
and 10. Thus it was decided that the implants should be removed before skin grew over 
the top of the exposed posts (Figure 23). Upon removal, it was evident that soft tissue in-
growth had occurred not only at the base of the button but also through the posts that 
were still attached and the posts that were snapped off (Figures 24 and 25). As with 
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Rabbit #3, a slight amount of subcutaneous irritation was noticed at the cranially located 









































Figure 25: Soft tissue in-growth into the post of a button from Rabbit #4. 
 
Table 2: Rabbit Implantation Information 
 
Rabbit Implant Information 
1 
400 and 800 micron dodecahedral blocks (two each) 
implanted subcutaneously 3/19/2012. Implants removed 
4/20/2012. 32 day implantation. 
2 
400 and 800 micron dodecahedral blocks (two each) 
implanted subcutaneously 3/19/2012. Implants removed 
5/11/2012. 53 day implantation. 
3 
1200 micron dodecahedral blocks (four) implanted 
subcutaneously 4/20/2012. Implants removed 5/11/2012. 
21 day implantation. 
4 
1200 micron dodecahedral buttons (four) implanted 
subcutaneously 4/20/2012. Implants removed 5/11/2012. 






 At the time of the submittal of this thesis, only the histological results from the 
first implant removal (Rabbit #1) were available. After fixing and staining cross sections 
of the implants, as described in the Materials and Methods Section of this report, the 
slides were examined under a microscope.  
 Examination of sections of a coronal sectioned 400 micron dodecahedron block 
revealed evidence of slight in-growth of cells, in addition a thin layer of fibroblast cells 
was observed around the edges of the implant. Analysis of the cellular morphology 
revealed that the cells within the implant were predominately necrotic.  
Subsequently, sections from an 800 micron dodecahedron block were examined. 
It is noted that sections from this block demonstrated tissue attachment in vivo as well as 
apparent tissue in-growth and vascularization. Histologic examination of a coronal 
section of a 800 micron dodecahedron block showed areas of both necrotic cells (Figure 
26) and granulomatous tissue indicating an immune response (Figure 27). Also identified 
were mast cell aggregates, neutrophils, syncytial cells, and large aggregates of 
lymphocytes. These findings indicate an immune response, as well as the subsequent 
occurrence of defense mechanisms. In addition, the appearance of red blood cells 
surrounded by endothelial cells suggests the occurrence of neovascularization (Figure 
28). The presence of necrotic cells as well as the apparent immune responses, in both the 
400 and 800 micron dodecahedron blocks is most likely attributable to the cytotoxic 














Figure 26: Necrotic cells present in a coronal cross-section  












Figure 27: Granulomatous tissue and syncytial cells  


























 The objective of this study was to develop a porous polymeric implant, using 3D 
printing technology, which facilitated soft tissue in-growth for use in subcutaneous and 
percutaneous applications. Through the use of CAD software, and with the assistance of 
the AMC at the University of Maine, Orono, 3D designs for both porous subcutaneous 
and percutaneous implants were developed. With the assistance of the MAC at the 
University of Southern Maine, Gorham, the 3D designs were printed and evaluated. After 




trial. In addition, a cell culture experiment was performed to test basic cell adhesion and 
material biocompatibility. 
 The porous matrix comprised a repeated pattern of interconnected rhombic 
dodecahedra which are stacked on top of each other. The porous matrix was employed in 
a rectangular block for subcutaneous implantation, and a button shape for percutaneous 
implantation. The internal dodecahedral pore diameters of the implants tested in the small 
animal trial were 400, 800, and 1200 micron (approx). 
 Cell culture data indicated that the plastic material (Vero White Plus Fullcure 
835) employed to construct the implants was toxic to Buffalo Rat Liver cells and as such 
resulted in little to no cellular attachment. The small animal trial demonstrated that the 
400 micron subcutaneous blocks did not facilitate tissue attachment or tissue in-growth. 
However, the 800 micron dodecahedron blocks, 1200 micron dodecahedron blocks, and 
1200 micron dodecahedron buttons all achieved considerable tissue attachment and soft 
tissue in-growth based on gross anatomical analysis. 
 Histologic examination of the in vivo implants indicated overwhelming necrosis 
and immune response of the in-grown tissue, although neovascularization was observed. 
The histological results are likely attributable to the cytotoxic nature of the implant 
material used. 
 In conclusion, although the non-biocompatible nature of the implant material 
resulted in necrosis of the in-grown tissue in vivo neovascularization and gross 
anatomical analysis suggests that the implants were successful in meeting the objective of 
facilitating soft tissue in-growth. Ongoing work is focused on repeating the study with 
blocks and buttons made from a known biocompatible polymer. In addition, further work 
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will be performed to refine both the pore and overall implant designs. Potential 
applications for implant designs that did not demonstrate tissue in-growth (i.e. 400 
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APPENDIX C: Sterilization Test 
STERILIZATION TEST 
1. Place one 400 micron dodecahedron button, 400 micron dodecahedron block, and 
800 micron dodecahedron block in individual 50mL conical tube. Add 7.5% 
hydrogen peroxide (H2O2) to each of the three conical tubes until implants are 
completely submerged. 
2. Place 50mL conical tubes on rocker for 20min. 
3. Remove 50mL conical tubes from rocker and decant H2O2 from each tube. 
4. Add 70% ethanol (EtOH) to each of the three conical tubes until implants are 
completely submerged. 
5. Place 50mL conical tubes on rocker for 20min. 
6. Remove 50mL conical tubes from rocker and decant EtOH from each tube. 
7. Add sterile RPMI-1640 culture medium (Sigma-Aldrich) to each of the three 
conical tubes until implants are completely submerged. 
8. Place 50mL conical tubes on rocker for 5min. 
9. Remove 50mL conical tubes from rocker and decant RPMI-1640 culture medium 
from each tube into separate sterile 50mL conical tubes. 
10. Aseptically streak ~20μL of RPMI-1640 culture medium decanted from each tube 
in step 9 onto separate halves of P1100 blood agar plates (TSA w/5% sheep blood 
– Northeast Laboratory Services). 
11. Aseptically streak ~20μL of RPMI-1640 culture medium onto one half of P1100 




12. Incubate blood agar plates from steps 10 and 11 at 37oC for 48hr. 






















APPENDIX D: Cell Culture Experiment 
CELL CULTURE EXPERIMENT 
1. Thaw Buffalo Rat Liver (BRL 3A) cells (ATCC biological resource center) and 
then propagate in Minimum Essential Medium Eagle (Sigma-Aldrich) in a 37
o
C 
humidified incubator with 5% CO2 in air. 
2. Allow cells to culture for several days until 80-90% confluent growth on bottom 
of tissue culture flask is observed. 
3. Upon observation of 80-90% confluent growth remove tissue culture flask from 
incubator. Decant medium and rinse with 10mL of serum-free Minimum Essential 
Medium. 
4. Re-suspend cells by adding 7mL of 0.25% Trypsin-EDTA (Sigma-Aldrich) to 
tissue culture flask.  
5. After 10min pour cell suspension from tissue culture flask into 50mL centrifuge 
tube. Add 10% fetal bovine serum in Minimum Essential Medium to centrifuge 
tube to stop effects of trypsin and stabilize cells. 
6. Centrifuge cell suspension at 1050 rpm for 7min using a slow deceleration. 
7. Decant supernatant from centrifuge tube and re-suspend pellet by adding 
Minimum Essential Medium and gently aspirating with pipette. 
8. Analyze cell concentration of suspension resulting from step 7 using a 
hemocytometer. 
9. If needed, add additional Minimum Essential Medium to cell suspension to 
increase total volume and obtain appropriate cell concentration for seeding 
implants. Analyze cell concentration of diluted suspension using hemocytometer. 
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10. Place sterilized implants, plastic material, or support material into individual wells 
of sterile 8-well tissue culture plates. 
11. Seed objects in step 10 with cell suspension in step 9 by adding 4-5mL of cell 
suspension to each well. Add 4-5mL of cell suspension to empty wells as control. 
12. Place tissue culture plates in 37oC humidified incubator with 5% CO2 in air for 
24hr. 
13. Remove tissue culture plates from incubator and use an inverted microscope to 



























APPENDIX E: IACUC Protocol 
IACUC PROTOCOL REVIEW FORM 
PROTOCOL NUMBER:        August 2010 version 
 
 
UNIVERSITY OF MAINE 
PROTOCOL REVIEW FORM 
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE 
 
 
GENERAL INSTRUCTIONS:  The Institutional Animal Care and Use Committee (IACUC) 
consists of scientists from several disciplines as well as non-scientists, members of the University 
community, and persons who have no other affiliation with the University than as members of the 
Committee.  The protocol should therefore be described in terms understandable by an audience 
of educated nonspecialists.  Please return the completed protocol to the Institutional Animal 
Care and Use Committee, c/o Office of the Vice President for Research, 114 Alumni Hall.  
The form is due TWO weeks prior to a scheduled IACUC meeting.  The meeting dates are 
posted at: http://www.umaine.edu/research/research-compliance/institutional-animal-care-and-use-
committee-iacuc/meeting-schedule-and-protocol-due-dates/.  Protocols received late will be held 
until the next month’s meeting.  Please call Gayle Jones at 1-1498 if you have questions.      
 
The Principal Investigator or Instructor must justify the ethical costs of using live animals by 
demonstrating a reasonable expectation that such usage will contribute to the advancement of 
knowledge which may eventually benefit humankind and/or animals.  The Principal Investigator 
or Instructor must further demonstrate that he or she has applied the concepts of "alternatives" in 
designing the protocol.  The term “alternatives” includes three components:  replacement (using 
organisms that are phylogenetically lower, cell cultures, tissues from slaughter or autopsy, or 
nonanimal systems); reduction (in the number of animals used); and refinement (of design and 
methods to reduce pain and stress to animals used as well as ensuring that the number of animals 
used is optimal for the analysis proposed).   
 
 1. Principal Investigator, Co-Investigator(s), or Instructor(s), with campus address, office 
phone, and lab phone of PI (NOTE:  The Principal Investigator or Instructor must be a 




James A. Weber, DVM, PhD 




Ian D. Dickey, M.D., F.R.C.S.C.,  
Medical Director, Orthopaedic Oncology, Adult Reconstruction 




Department of Chemical and Biological Engineering, Univ. of Maine 
417 State Street – Suite 20 
Bangor, Maine, U.S.A. 04401 
(207) 973-8840 
 
David Neivandt, Ph.D. 
Associate Professor 
Dept. of Chemical and Biological Engineering, University of Maine 
581-2288 
 
Anne Lichtenwalner, DVM, PhD 
Dept. of Animal and Veterinary Sciences, Univ. of Maine, 581-2789 
  
Title and number of course/Title of project:   
 
In-Vivo Evaluation of Skin and Subcutaneous Tissue In-Growth into Porous Polypropylene 
Implants Using a Rabbit Implant Model 
 
Project/Course Start Date: January 1, 2012 
 
Number of years project is planned to continue: three 
(IACUC approval is granted for three years) 
 
If this is a renewal application, please enter the exact project or course title and previous protocol 




 Funding agency for project, if applicable.  Include title of proposal if different from this 
protocol.   
 
 Internal UMaine Funding sourced from the Institute for Molecular Biophysics, together 
with a  Carolyn E. Reed Pre-Medical Thesis Fellowship 
 
2. Describe the (check appropriate category) __X__research, ____teaching, or 
____production objectives (not procedures) that involve use of animals.  Explain these 
objectives in non-technical language.  Do not paste in sections of grant proposals. 
 
The importance of soft tissue fixation in total joint, tumor, tendon and ligament 
reconstruction is becoming increasingly apparent throughout the field of 
orthopaedic surgery. The inability to successfully form a water tight seal between 
skin and currently available transcutaneous orthopedic devices results in early 
implant failure due to infection of deep tissues and bone.  The inability of soft tissue 
to form a strong attachment to solid metal implants is currently a significant cause 
of limited postoperative function in orthopedic procedures such as external fixation 
of fractured limbs.  Work completed by this group and by others has demonstrated 
that orthopedic implants composed of metal foams with pores of trabecular 
architecture allow ingrowth of both bone and soft tissue to form a strong tissue-
device attachment.  While early work has shown promise, two major issuse remain:  
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First,  can transcutaneous foam implants form a watertight seal with healing skin 
that excludes bacteria from deeper tissues; and second, can non-metallic materials 
currently used in orthopedic devices (high density polypropylene, for example) be 
modified to stimulate tissue-implant adhesion through the introduction of small 
pores into the material? To our knowledge, there is no such attempt to quantify 
these factors for soft tissue, including skin and subcutaneous tissues. 
This study tests the ingrowth of skin and subcutaneous tissue in rabbits to 
"buttons" made of a novel polypropylene foam that is built on a three dimensional 
printer. Our objectives are to compare ingrowth of skin and subcutaneous tissues 
into plastic foam devices that are surgically implanted through the skin of rabbits.  
We plan to quantitate the degree of in-growth of rabbit cells into the porous 
matrices of these implants. Rabbits will be sacrificed and implants harvested at 
three or six weeks post-implantation,  and implants will be evaluated grossly for 
tissue form, and histomorphologically for tissue-prosthetic ingrowth. The 
comparision between groups will be to determine if the rates of ingrowth are 
comparable or different, and within each group, what degree of ingrowth is evident 
on histologic examination.  
 
3. Describe how this use of animals contributes to the advancement of knowledge, which 
may eventually benefit humankind and/or animals. 
 
Orthopaedic reconstructive surgery has improved the lives of many people since the 
development of the hip replacement. Despite the success of today's orthopaedic implants, 
significant morbidity, functional loss, and ultimate prosthetic failure is all-too-often 
associated with these procedures. The inability to successfully reattach soft tissue (skin, 
tendons and ligaments) directly to endoprosthetics is a significant limitation of current 
orthopaedic implants. This study focuses on a new method for soft tissue attachment to a 
novel non-metal endoprosthesis.  This and future studies will offer new opportunities to 
improve the success of external fixation of fractures and soft tissue reconstruction by 
decreasing current orthopaedic postoperative infection rates in human patients. 
 
4. Identify the animals to be used (genus and species) and number (for the entire project).  
 
 Domestic rabbit (Oryctolagus cuniculus; New Zealand White strain, 4 to 4.5 kg each).   
n = 6 animals) 
 
5.   State the rationale for use of this/these species.  Address the issue of replacement by 
explaining why educational or research objectives cannot be met by the use of 
phylogenetically lower organisms, cell or tissue cultures, or non-animal systems.  (Please 
note:  the IACUC does not consider "hands-on experience" to be in and of itself an 
adequate educational objective, unless the course serves students whose anticipated 
educational and professional futures will require the skills imparted through such hands-
on experience.  If that is true in this instance, please describe the student population that 
typically enrolls in the course.) 
 
The objective of this study is to predict the interactions of various porous orthopedic 
implants with surrounding tissues during the post-surgical recovery period in human 
patients.  A variety of systemic interactions occur during wound healing, and there are no in 
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vitro options that accurately mimic the local conditions, cell types and immune system 
interactions that occur in a live mammal.  
 
6. Justify the number of animals: 
 
a. Explain how the number of animals required fits your experimental design or 
teaching or production/breeding objectives. 
 
This is a pilot study where we plan to use small numbers of animals to 
determine the growth of soft tissue into previously untested implant material.  We plan to 
initially test the biocompatibility of  plastic orthopedic discs that are taped to the skin of 
rabbits.  If the material shows no reaction after seven days, we then plan to subcutaneously 
implant solid implants of the plastic material  into the same two rabbits (one implanted for 
three weeks post-surgery, and the other for six weeks).  If the initial study shows that the 
material is biocompatible with subcutaneous tissues, and subcutaneous tissues grow into the 
foam implants, then we will conduct a second study where we compare the growth of skin 
and subcutaneous tissues into plastic foam implants within the same animal.  This study will 
use an additional four rabbits, two sacrificed at 3 weeks post-surgery and two sacrificed at 
six weeks post-surgery.  In this case, a disc-shaped plastic foam implant with a cylindrical 
process will be implanted so that the implant contacts both subcutaneous tissues and skin, 
and a portion of the cylindrical process extends above the surface of the skin so that it is in 




b. Give the rationale for the number in terms of the statistical methods to be used.  
Address the issue of reduction by explaining why the proposed number is 
sufficient, but not excessive.  (A simple statement that the number proposed is 
required for statistical significance is not an adequate response.)  See How to do a 
Power Analysis.  For research in which the number of animals is limited not by 
statistical power, but by the number of animals that can be captured, maintained, 
or sampled, a power analysis will provide an indication of the statistical power of 
the proposed tests based on the variance measured by the researcher, or others, in 
previous studies.  For studies not amenable to a Power Analysis (e.g., no data on 
variability available, only descriptive data available), provide a justification for 
why a power analysis is not appropriate for your project.  
 
This is a pilot study where we plan to obtain results that may be used as preliminary data to 





The Committee does not wish to receive copies of research proposals or laboratory manuals.  The 
Principal Investigator or Instructor is asked to address succinctly the following questions, 
as applicable.  Special care should be taken to justify any procedures generally 




a. Major categories of procedures.  Please check the appropriate box for each 
category.   
 
 Any “yes” responses must be described in sections b. (nonsurgical 
procedures) and/or c. (surgical procedures) that follow.  Please attach the 
category headings (from 1-16 below) to the description of procedures in 




  1. collection or capture 
  2. kill and harvest tissue 
  3. immunization for antibody production:  describe antigen, adjuvant used, 
route of immunization, method of obtaining blood 
  4. physiologic measurements 
  5. dietary manipulations 
  6. pharmacology/toxicology:  material used, route of administration, etc. 
  7. behavior studies 
  8. environmental stress, e.g., temperature, restraint, forced exercise 
  9. irradiation:  type, facility to be used 
  10. hazardous materials, e.g., carcinogens, radioactive materials 
  11. biohazardous or infectious agents (use of Class 2 or higher agents 
requires the approval of the University's Biosafety Committee)  
  12. experimental trauma 
  13. nonsurvival surgical procedure 
  14. survival surgical procedure (animal is allowed to recover for any length 
of time) 
  15. multiple major operative procedures from which animal is allowed to 
recover   
  16. other, specify:  
Skin surface testing of plastic implants for chronic inflammatory response 
 
b. Nonsurgical Procedures: 
 
Describe all nonsurgical manipulations or procedures, if any, involving the 
animal, e.g., drug administration, blood collection, diet change, collection, 
capture.  Specify the drug(s), dose, route of administration, or other methods 
used.  Specify duration of procedures.  If an adjuvant will be used, state the 
number of injection sites per dosage and the number of doses. 
 
Rabbits will be transported to the Small Animal Research Facility at least one week prior to 
surgery to allow a period of acclimatization. Animals will be examined for general health 
and normal feeding / grooming behavior daily for the duration of the project.  At twice 
weekly intervals, rabbits will be subjected to a more thorough physical exam and will be 
weighed. 
 
Skin test - We plan to initially test the biocompatibility of  plastic orthopedic discs that are 
taped to the shaved skin of rabbits.  The plastic discs will be affixed using medical grade 
bandages to a site where the rabbits will not be able to remove them, and will remain for 7 
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days.  Following the skin test, the skin will be visually examined for signs of an 
inflammatory reaction to the plastic. 
 
Will the animals be killed?  If so, what method of euthanasia will be used?  
(Include dosages if applicable.)  See the 2007 Report of the AVMA Panel on 
Euthanasia for assistance 
(http://www.avma.org/issues/animal_welfare/euthanasia.pdf).  If not, what final 
disposition of the animals is planned? 
 
Rabbits will be humanely euthanized at the end of the post-surgery recovery period (either 
three or six weeks) by an overdose of sodium pentobarbital (88 mg/kg of body weight) that 
will be injected intravenously.   All euthanasia will be performed by Dr. Weber, DVM, PhD. 
 
If euthanasia becomes necessary, due to unplanned injury or illness to the 
animal(s), how will it be accomplished (include dosages if applicable)?  See the 
2007 Report of the AVMA Panel on Euthanasia for assistance 
(http://www.avma.org/issues/animal_welfare/euthanasia.pdf). NOTE:  question must 
be answered. 
 
In the event of an unplanned injury or unanticipated post-surgical complication, rabbits 
will be humanely euthanized by an overdose of sodium pentobarbital (88 mg/kg of body 
weight) that will be injected intravenously.   All euthanasia will be performed by Dr. 
Weber, DVM, PhD. 
 
c. Surgical Procedures: 
 
Describe briefly any surgical procedures.  Describe the anaesthetic method, 
including all drugs, dosages, routes of administration, and supplementation 
schedules.  Describe the postsurgical monitoring and care procedures, including 
what response(s) you will look for to indicate recovery, and the method of 
euthanasia (if it becomes necessary due to unplanned injury or illness).   
The orthopedic implants will be composed of a biocompatible plastic 
material.  Internal structure of the implants will either be of a foam-type 
with a trabecular inner structure and a defined pore size, or solid, with no 
internal structure (control implants).  The implants will be made from 
Durus White Fullcure 430, a polypropylene-like material with desired 
mechanical properties. The three-dimensional implants will be 
manufactured by the Advanced Manufacturing Center (AMC) at the 
University of Maine, using an Objet rapid prototyping machine.  
 
After appropriate anesthesia (induction with xylazine (6 mg/kg i.m.), then 
ketamine (25-30 mg/kg i.m.)), each rabbit will be maintained in a surgical 
plane of anesthesia via inhalant isoflurane that is delivered through a close-
fitting surgical mask covering the mouth and nose.  After rabbits are in a 
surgical plane of anesthesia, a superficial posterior approach to the 
subcutaneous layer overlying the spine will be performed through a single 
incision through the skin directly on the dorsal midline from the mid thorax 
to the lumbar region of the back. This skin incision will be approximately 12 
to 15 cm in length.  For the initial two surgeries, where a rectangular block 
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of high density polypropylene foam is inserted subcutaneously, four pockets 
(one on each side of midline) will be created between the skin and the dorsal 
paraspinal muscles for insertion of the four plastic implant blocks.  Two 
blocks will have a trabecular foam structure (pore size of 527 micrometers 
and a strut thickness of 122 micrometers), and two will be made of solid 
plastic using the same material.  Each block will be rectangular in shape, 
with dimensions of 4 cm x 3 cm x 1 cm.  The blocks will be spaced about 4 
cm from each other between the subcutaneous tissue and the fascia. In each 
pocket, the block will be secured by anchoring it with vicryl sutures at 
opposite corners. After block placement, the wound will be irrigated and a 
layered closure will be performed with subcuticular closure and a sterile 
dressing. The dressing will be mildly compressive in nature. 
 
Upon successful recovery and healing of the subcutaneous foam blocks 
within the two initial rabbits, transcutaneous "buttons" made of high 
density polypropylene-like foam will be implanted into the subcutaneous 
tissues of four additional rabbits. The surgical anesthesia and approach will 
be similar to the initial two surgeries, but four smaller incisions (one for 
each implant) will be made into the skin overlying the dorsal paraspinal 
muscles at the level of the thorax (two incisions just left of center and two 
just right of center).  A plastic implant with a larger (2 to 3 mm in diameter) 
oval-shaped base attached to a smaller (0.7 cm in diameter and about 1 cm 
tall) cylindrical projection will be affixed between the skin and the 
underlying tissues so that the small cylindrical portion spans the trans-
cutaneous junction and extends above the skin.  The larger oval portion will 
remain in the subcutaneous space to act as an anchor.  After implant 
placement, the wound will be irrigated and a layered closure will be 
performed with subcuticular closure and a sterile dressing. The dressing will 
be mildly compressive in nature. 
 
Our main post-operative concerns will be the pain associated with the 
healing of the skin wounds and the subcutaneous pockets, and the risk of 
post-operative infection of the implant sites.  To minimize these 
complications, rabbits will receive standard intra-operative and post-
surgical care.  Surgeries will be performed by an orthopedic surgeon with 
assistance by a veterinarian and veterinary technician in a veterinary 
surgical suite.  All personnel in the operating theater will be appropriately 
gowned, and strict sterile technique and maintenance of sterile fields will be 
followed.  Rabbits will be kept warm throughout the procedure with a 
pediatric surgical warming unit, and their vital signs will be monitored 
regularly by the veterinary technician through physical signs and with an 
electronic unit that monitors the rabbit's pulse rate and tissue oxygen 
saturation.  All animals will be given antibiotics (cefazolin at 25 mg/ kg i.m. 
at one hour pre-op, and at 12 hour intervals post-op for at least 24 hours), 
non-steroidal anti-inflammatory agents (5 mg/kg of carprofen s.c. at one 
hour pre-op, and at 24 hour intervals post-surgery for one to two doses) and 
a morphine agonist for analgesia (buprenorphine at 0.01 mg/kg immediately 
post-wound closure, then at 12 hour intervals post-surgery until activity 
patterns and feeding behavior have returned to normal levels). They will 
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receive appropriate care from the staff of the Lab Animal Facility under the 
supervision of Dr. Weber.   Indications of pain or distress (i.e., cowering, 
agitation, lack of defecation/ urination or lack of interest in food ) and post-
operative complications (gross decrease in body weight, self mutilation, 
overwhelming sepsis, wound abscesses or ulcers) will be addressed through 
additional veterinary care (all workers in the lab animal facility will be 
trained to recognize these signs of distree in the post-operative rabbits). 
Rabbits that do not respond to treatment will be removed from the study 
and humanely euthanized with an overdose of sodium pentobarbitol as listed 
in Section 7a.  At the end of the post-operative recovery period, rabbits will 
be sacrificed as described in Section 7a.  Following euthanasia, each plastic 
implant  and surrounding soft tissue will be harvested en bloc, taking care to 
avoid disruption of the skin/ implant interface.  The tissue will be prepared 
for histological sectioning and microscopic examination to assess the degree 
of tissue invasion of the spaces within the trabecular foam implants. 
 
Is animal allowed to recover for any length of time?  Yes/No Yes.  If yes, how 
long will animal survive surgery?  
 
Three weeks post-surgery (n=3) or six weeks post-surgery (n=3). 
 
If there is potential for discomfort or pain as a result of the procedures, describe 
their nature and duration.  Explain what will be done to relieve them, including 
drugs and dosages, nursing care, mechanical devices, etc. 
 
See response in section describing surgical and post-surgical procedures. 
 
d. Search for Alternatives:  If the proposed procedures cause more than momentary or slight 
pain or distress to the animal(s), federal regulations require that you search for 
alternatives.  The PI must provide a written narrative description (see NOTE below) of 
the sources used to determine that less painful alternatives are not available.  To fulfill 
this requirement, bibliographical searches may be performed through the Animal Welfare 
Information Center (AWIC) of the National Agriculture Library 
(http://awic.nal.usda.gov/nal_display/index.php?info_center=3&tax_level=1&tax_subject=184). 
 
 Will the proposed procedures cause more than momentary or slight pain or distress to the 
animal(s)? 
 
  No.  (Examples of procedures for which this response is appropriate include 
observation of behavior under conditions of little or no distress, dietary 
manipulations, and injections or blood sampling by qualified personnel.) 
 
 
 Yes.  (Examples of procedures for which this response is appropriate 
include survival surgery, nonsurvival surgery, electrofishing, and 
procedures producing pain or distress unrelieved by analgesics such as 
toxicity studies, microbial virulence testing, radiation sickness, and 




 NOTE:  When preparing the narrative, the instructions in the USDA 
policy MUST be followed.  For a description of this policy, see: 
http://www.aphis.usda.gov/animal_welfare/downloads/policy/policy12.pdf. 
   
 
Animal Welfare Information Search 
 
Databases searched were Medline and the AWIC site.  Both sites were searched on November 1, 
2011. 
  
Medline Search ID # S1 ((orthopedic surgery) or (porous plastic foam) or (trabecular plastic) or 
(soft tissue reconstruction) or (endoprosthesis)) and non-surgical. Limiters - Date of Publication: 
1995/01-2011/11; Abstract Available; Languages: English; Animals: Rabbits 
Expanders - Automatically "And" search terms  Interface - EBSCOhost 
Search Screen - Advanced 
Database - MEDLINE 59 hits 
 
The Medline search did not reveal non-surgical alternatives that would adequately address the 
interactions of mammalian tissues with the type of implants used in the proposed study.  
Furthermore, the only study design that is Federally approved for pre-clinical studies of human 
prosthetics is a mammalian whole animal model, and the ultimate goal of the proposed work is 
the development of an orthopedic device that could be used in human medicine. 
 
AWIC Website.  After examining the resources on the website, we found that the most useful link 
for our discipline was the AltWeb site.  AltWeb Search:  We examined articles in this database, 
but did not find alternatives to surgery for the proposed study.  We did find useful information on 
side effects of specific anesthetic combinations in rabbits, and guidelines for the recognition and 
assessment of animal pain.  This information was incorporated into the IACUC proposal. 
 
 NOTE:  When proposed procedures will cause more than 
momentary or slight pain or distress to animal(s), a consultation 
with the attending veterinarian must occur in the planning 
stages of those procedures prior to submitting this protocol for 
review.  Please email Dr. James Weber, james.weber@umit.maine.edu, 
with a description of the proposed procedures and your approach to 
minimizing pain/distress.   
 
8. Animal Sources and Housing    
 
a. Please indicate source of animals.  Note:  The IACUC will approve animal purchases 
from a licensed pet store provided the researcher/instructor informs the pet store 
(in writing) that the purchased animals will be used for research/teaching.   
New Zealand White rabbits will be obtained from Charles River 
Laboratories. 
 
b. If the animals are caught in the wild:  n/a 
 Where and how will the animals be trapped?          
 How often will the traps be checked?            
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 What other steps will be taken to protect the animals from exposure or other danger?         
 Indicate if Federal/State permits are required and whether they have been obtained.         
 If the animals will be brought to the campus, what precautions will be taken to prevent 
zoonotic diseases?          
 Please include your plans for removal of traps or barriers (e.g., pitfall traps).   
      
c.   Where will the animals be housed?  Describe the housing (See the Guide for the 
Care and Use of Lab Animals (http://www.nap.edu/readingroom/books/labrats/) 
pages 22-36) for information on Physical Environment, including space 
requirements.  If your housing will not meet the Guide requirements, include a 
request for an exception to the Guide.  If your animals are not listed in the Guide, 
housing should meet the recommendations of the appropriate guidelines for the 
proposed species.  Include dimensions of cage, tank, etc.    
 
Rabbits will be housed one animal per cage in standard laboratory rabbit 
cages (stainless steel bars, with slotted plastic floor, dimensions = 18 inches high by 26 
inches wide by 26 inches deep.  These cage dimensions will allow rabbits in the 4.0 kg weight 
range to stand up in and move freely about the cage) within one of the animal rooms in the 
Small Animal Research Facility on campus. Rabbits will be housed individually, but will 
have visual and auditory contact with other rabbits in the same room.  Rabbits will be given 
enrichment items (i.e., rabbit-safe gnaw toys), and will receive daily human contact from 
the animal caretakers.  
 
d. Identify the room or facility in which the procedures will be conducted. 
 
Housing - one of the five lab animal rooms in the Small Animal Research Facility.   
 
Surgeries - performed in the surgery suite within the Small Animal Research Facility - 
includes dedicated pre-operative, operative and post-operative areas, and HEPA filtered 
ventilation within the surgery room. 
 
 
 9. List all person(s) (including PI) who will handle animals (e.g., carry out the procedure(s), 
animal care, etc.) or provide training of personnel.  For each person named below, 
describe his/her experience in performing proposed procedures; if none, explain how 




James Weber, DVM, PhD.  Dr. Weber is a licensed veterinarian (DVM in 1994) with training 
and over twenty years of experience in the anesthesia and surgery of laboratory animals, 
including rabbits, rats, mice and laboratory swine.  He and Dr. Dickey successfully completed 
an orthopedic surgery-based study of 36 rabbits at UMaine in 2007. 
 
Ian Dickey, MD, FRCSC.  Dr. Dickey is a licensed orthopedic surgeon who is currently 
practices in the orthopedic reconstruction center at Eastern Maine Medical Center.  He is also a 
cooperating research professor in the Department of Biological and Chemical Engineering.  Dr. 
Dickey has been the primary investigator for numerous orthopedic research studies  in the area 
of tissue ingrowth into foam metal implants, and he routinely performs orthopedic and 
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reconstructive surgeries on human patients in his current practice at EMMC. 
 
Dr. Anne Lichtenwalner is a veterinary scientist who currently does animal-related research 
and oversees Maine's Animal Health Laboratory.  She has over twenty years of experience with 
lab animal medicine, and acted as the Institutional Veterinarian for the University of 
Washington.  Anne also has extensive experience with a variety of surgical and non-surgical 
procedures on both large and small animals.   
 
Brenda Kennedy-Wade.  Brenda is a  veterinary technician who is currently licensed in the 
State of Maine.  She has been the professional staff member in charge of animal care at the 
Small Animal Research Facility for over ten years.  She has also assisted investigators in 
virtually all of the surgery and post-operative care that has been conducted at the SARF during 
that time.      
 
Alex Caddell. Alex is a senior biological engineering student at the University of Maine and will 
be involved with the research as part of his Honors Thesis project. Training will be obtained 
from Dr. Weber and Dr. Dickey. Alex will observe the surgeries, but will not be part of the 
surgery team.  He will be a member of the post-operative animal monitoring team.        
 
10. If animals will be housed, please list the name, phone number, and email of the person 
who should be contacted to accompany the IACUC during facility inspections: 
 
Brenda Kennedy-Wade, 581-2775; brendakw@maine.edu 
 
11. Have all personnel named above been certified by the IACUC for Responsible Care and Use 
of Animals?   
  Yes      No     A web-based tutorial for this certification is available at:  
http://umaine.edu/research/research-compliance/institutional-animal-care-and-use-committee-




12. Risk Assessment (risks to researchers): 
 
 In compliance with our Public Health Service Animal Welfare Assurance, we have 
implemented an Occupational Health/Medical Surveillance Program.  The first step will 
be for investigators to identify potential hazards with tasks involved with the study, so the 
IACUC veterinarian and Safety and Environmental Management (SEM) can assess the 
risks to determine if further information will be required from everyone named in the 
protocol (i.e., a health questionnaire).   
 
 Please complete the following for your proposed protocol.   
 
 
a) Provide a brief description of the protocol (cut and paste response from question 
2 of the protocol).  (NOTE:  Only this page, not the whole protocol, goes to SEM 
and the Occupational Health Physician, thus the request for duplication of the 
answer to question 2.) 
The importance of soft tissue fixation in total joint, tumor, tendon and ligament 
reconstruction is becoming increasingly apparent throughout the field of 
orthopaedic surgery. The inability to successfully form a water tight seal between 
skin and currently available transcutaneous orthopedic devices results in early 
implant failure due to infection of deep tissues and bone.  The inability of soft tissue 
to form a strong attachment to solid metal implants is currently a significant cause 
of limited postoperative function in orthopedic procedures such as external fixation 
of fractured limbs.  Work completed by this group and by others has demonstrated 
that orthopedic implants composed of metal foams with pores of trabecular 
architecture allow ingrowth of both bone and soft tissue to form a strong tissue-
device attachment.  While early work has shown promise, two major issuse remain:  
First,  can transcutaneous foam implants form a watertight seal with healing skin 
that excludes bacteria from deeper tissues; and second, can non-metallic materials 
currently used in orthopedic devices (high density polypropylene, for example) be 
modified to stimulate tissue-implant adhesion through the introduction of small 
pores into the material? To our knowledge, there is no such attempt to quantify 
these factors for soft tissue, including skin and subcutaneous tissues. 
This study tests the ingrowth of skin and subcutaneous tissue in rabbits to 
"buttons" made of a novel polypropylene foam that is built on a three dimensional 
printer. Our objectives are to compare ingrowth of skin and subcutaneous tissues 
into plastic foam devices that are surgically implanted through the skin of rabbits.  
We plan to quantitate the degree of in-growth of rabbit cells into the porous 
matrices of these implants. Rabbits will be sacrificed and implants harvested at 
three or six weeks post-implantation,  and implants will be evaluated grossly for 
tissue form, and histomorphologically for tissue-prosthetic ingrowth. The 
comparision between groups will be to determine if the rates of ingrowth are 
comparable or different, and within each group, what degree of ingrowth is evident 




 b) List the tasks required. 
 
 1.  Care and feeding of rabbits. 
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2.  Surgical prep, general anesthesia surgery, surgical post-op, euthanasia using 
pentobarbital overdose. 
3.  Administration of i.v. and i.m. injections, physical examination, bandaging of 
post-operative wounds. 
 
 c) For each of the tasks described in b) above, list the associated hazards. 
 
  1.  Animal bites and scratches, risk of being kicked by rabbit hind limb. 
  2.  Possible exposure to anesthetic drugs, risk of needle stick. 
  3.  Needle stick, risk of being bitten or scratched , development of allergies. 
 
d) For each of the hazards described in c) above list how the hazards will be 
managed. 
 
1. All animal workers will receive hands-on training on the safe methods for 
handling rabbits prior to their work in the animal room.  Animal care workers 
will wear nitrile gloves, eye protection and disposable coveralls during routine 
care and feeding of rabbits.  We do not anticipate that these animals will be 
overly aggressive, based on their performance in many research studies. Heavy 
canvas gloves will be worn when animals are handled. 
2.  All drugs will be handled and administered by trained personnel (Weber, 
Kennedy-Wade), and University of Maine-approved procedures for handling 
needles, scalpels and other sharps will be followed.  Gas anesthetics are 
scavenged out of the surgery room using an active ventilation system. 
3.  Protective equipment will be worn (as described in “1.”, and trained personnel 
will perform all hands-on procedures with the rabbits (as described in “2.”.  
Animal room and surgery suite are actively ventilated, which minimizes 
exposure to potential allergens.  Workers cleaning up bedding and animal wastes 
will wear a particulate filtration mask to minimize inhalation of particulates. 
 
NOTE: In evaluating this risk assessment statement, we will be looking for animal care tasks that 
increase the risk of illness (such as a zoonotic disease), physical injury (such as animal bites), 
and/or allergic reactions to those handling the animals. 
 
After this risk assessment is reviewed, everyone named in the protocol may be required to 
complete a health questionnaire.  The health questionnaire may require review by the 
Occupational Health Physician.  If so, there is a charge for this review, and you will be 
required to provide an account number.  (Currently the charge is $45; we do not know the 
cost of a physical exam if warranted after review of the questionnaire, but this page will be 
updated when that information is known.)   
 
If you have any questions regarding the completion of this page, please contact James 
Patrick, Safety and Environmental Management, 1-4055.   
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ASSURANCES FOR THE HUMANE CARE AND USE OF ANIMALS 
 
As the Principal Investigator on this protocol, I assure that… 
 
1) I have provided an accurate description of the animal care and use protocol to be 
followed in the proposed project/course. 
 
2) the activities proposed do not unnecessarily duplicate previous experiments.   
 
3) all individuals named in this application who are at risk will be registered in the 
Occupational Health and Safety Program.   
 
4) all individuals performing animal procedures described in this application are technically 
competent and have been (or will be) properly trained in the procedures to ensure that no 
unnecessary pain or distress will be caused as a result of the procedures.   
 
5) I will obtain approval from the IACUC before initiating any changes to this protocol. 
 
6) I am familiar with and will comply with the University of Maine’s Policies and 
Procedures for the Humane Care and Use of Animals, and I assume responsibility for 
compliance by all personnel involved with this protocol.   
 
7) I have read and will follow the appropriate guidelines for the proposed species.   
 
8) if using laboratory animals, all personnel handling the animals have had a tetanus shot 
within the past ten years.   
 
9) all applicable rules and regulations regarding radiation protection, biosafety, recombinant 
issues, hazardous chemicals, etc., have been addressed in the preparation of this 
application and the appropriate reviews have been initiated.   
 
10) animals will be purchased only from licensed, reputable vendors.  If animals are 
purchased form a pet store, the pet store has been informed (in writing) that the animals 
will be used for research or teaching purposes.   
 
11) I will maintain appropriate animal records (e.g., census, health, veterinary care, 
euthanasia, surgery, diagnostic, anesthesia, etc.) 
 
12) I will report at once to the IACUC any unanticipated harm to animals. 
 
___________________________________________ _____________________ 
Signature of Principal Investigator/Instructor  Date 
 
I hereby confirm that I have read this protocol and my signature denotes departmental 
approval of this project. 
 
___________________________________________ ______________________ 
Signature of Department Head/School Director  Date 
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PROTOCOL NUMBER:  
 
Course/Project Title:   In-Vivo Evaluation of Skin and Subcutaneous Tissue In-Growth into 
Porous Polypropylene Implants Using a Rabbit Implant Model    
 
PI:     James Weber  
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_____ 1. Approved until ___________________ 
  Species and # of animals approved:  _________________________________ 
_____ 2. Modifications required.   
  Modifications accepted for approval:  _______________ Approved until:      ____________ 
  Species and # of animals approved:  _________________________________ 
_____ 3. Disapproved.  See attached statement. 
_____ 4. Reviewed and determined not to fall under the Policies and Procedures for the 
Humane Care and Use of Animals (explanation) 
________________________ 
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Purpose: 
The preservation of tissue samples. This SOP covers embedding tissue in paraffin block, 
sectioning tissue block and placement of section on glass slide. 
 
Hazards: 
Wear a long-sleeved lab coat, goggles and nitrile gloves. 
Formalin may cause severe irritation to skin, eyes and respiratory tract. While working 
with 10% BF it is mandatory to work under a fume hood or in a hood equipped with 






Sample jar containing 1:15 sample to fixative volume. 
Carbon steel blades – No.60 - No.8 handles  
Tissue-tek™ tissue cassettes 
No.2 pencil 
Hyper-Clean™ hood with formaldehyde clearing filter. 
Tissue processor 
Tissue embedding center 
Cold plate at - 4˚c  
Leica RM2155 Microtome 
Accu-Edge® Low Profile Blades. 
FisherBrand® Superfrost slides- 25mm x75mm x1mm 
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Water bath at 43˚-45c  
Warming plate at 40˚c 






1. Appropriately label specimen jar containing fixative. 
2. Place selected tissue into jar – if amount of tissue exceeds the 1:10 volume 
ratio, place excess tissue into additional specimen jar or add more fixative. 
3. Let tissue sit overnight [20-24hrs.] at room temperature. 
    Trimming: 
1. Trim tissue in Hyper-clean™ hood equipped with filter. 
2. Pour tissue into metal strainer over measuring cup, once drained deposit 
tissue onto trim board and pour fixative back into original specimen jar. 
3. Closely follow pathologist’s directions when trimming tissue, ie. near 
lesions and or special orientation of tissue, etc. 
4. Tissue must be less than 4mm in thickness. Do not crowd tissue. If 
possible, orient tissue exactly as it will be embedded in the paraffin block. 
Place side of tissue to cut face down in the cassette. 
5. Be sure to snap cassette lid tightly before placing into holding jar with 
10% BF. 
6. All samples remain in holding jar until the processing run begins. 
 
 Processing: 
1. Check the tissue processor to confirm each station contains the proper 
level of reagent. See S.O.P.: Operation of The Leica TP1020 Tissue 
Processor. 
2. Samples are processed in the Leica TP1020 overnight. The scheduled run 
lasts approximately 16.5 hrs. - samples are placed in the processor around 
4:00pm and removed the next morning around 8:30am. The processor 
will beep to signify the end of the run. 
3. Transfer the samples from the Leica TP1020 to the paraffin bath in the 
embedding center. 
 
             Embedding: 
1. Remove each cassette, one at a time,  from the paraffin bath and place it 
on the hot surface of the embedding center. Keep the cassette in contact 
with the hot surface or the paraffin will start to solidify. 
2. Select the proper sized metal mold and fill with paraffin. 
3. Open the tissue cassette and begin transferring the tissue to the mold using 
the warmed forceps sitting in the embedding center. The orientation of the 
tissue is very important. 
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4. Do not place the blunt end of the tissue piece toward the primary cutting 
edge of the block. If the knife hits the blunt end first it can create 
shattering artifacts.  
5. Once tissue is properly placed, slowly move mold to the cold area of the 
center and gently touch tissue to lock in place.Transfer cassettes to the 
cold plate to solidify the paraffin. The cold plate is kept at - 4˚c . 
6. After the paraffin hardens remove the block from the mold and trim away 
the excess paraffin.  
7. The sample is ready for sectioning. 
  
            Sectioning: 
1. Secure the tissue block in the microtome clamp and ALWAYS be 
consistent with the orientation of the block in the clamp. If re-cuts are 
necessary, the loss of sample is greatly reduced if the same orientation is 
kept. For reference, the cassette label is always facing the right when in 
the clamp. 
2. Insert microtome blade in the blade holder. An older blade can be used for 
rough cutting, but always use a new blade for fine sectioning. Use Accu-
Edge® Low Profile Blades. Gently wipe the edge of the blade with 
solvent prior to placing in the blade holder. 
3. The block must be rough cut to expose the entire face of all tissue in the 
block. 
4. Set the microtome at 15 or 30 microns to rough cut the block. 
5. After rough cutting, place the tissue onto an ice block. The tissue block 
must be cooled and moistened so that a suitable ribbon of tissue will 
advance from the block when sectioning.  
6. After approximately 30-45 min on ice, place block in the clamp and try 
cutting. 
7. Remember to place the new blade in the blade holder.  
 See SOP: Operation of the Leica RM2155 Microtome. 
8. When a nice, flat ribbon of tissue advances from the block, carefully lift 
the ribbon and float it onto the hot water bath [~ 44˚c], gently stretching 
the tissue to eliminate wrinkling. Select the best section from the ribbon 
and lift it off the water with the glass slide, lean slide upright against the 
water bath to dry.  
9. When dry, put slide onto slide warmer [~ 40˚c] to better adhere tissue 
section to the slide’s surface. Slides can remain on warmer overnight. The 
section is ready for staining. 
 
Procedural Notes 
            Please read referenced S.O.P.’s prior to following this protocol. 
 Proper instruction in the operation of the tissue processor and the microtome must 
be given  by lab personnel before processing any samples.  





 Laboratory Methods in Histotechnology, Armed Forces Institute of Pathology, 
1992 
            Leica RM 2155 microtome guide book. 
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Purpose 
 Operation of the Leica TP1020 tissue processor. 
 
Hazards 
1. Xylene is a moderate skin and eye irritant; toxic by ingestion, inhalation and skin 
contact. 
 Repeated exposure produces neurotoxic effects, impaired memory, mood swings 
and nerve  damage.Wear viton or Teflon gloves when dispensing.  
2. Ethanol is a moderate to severe skin irritant and moderate eye irritant; ix toxic by 
ingestion producing behavioral and gastrointestinal symptoms. Wear nitrile 
gloves when dispensing. 
3. Formaldehyde is a severe eye and skin irritant; toxic by ingestion and inhalation 
and is considered carcinogenic. Wear nitrile when dispensing. 
Specimen 
 Fixed tissue samples. 
 
Material Required 
1. 10% buffered formalin. 
2. Deinoized water 
3. Ethanol, 70%, 95% and 100% 
4. Xylene – Histological Grade 
5. Paraffin- Tissue Prep II 
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6. Fixed tissue samples 
7. Absorbent paper towels 
Procedure: 
Filling stations with reagents: 
1. Remove each container from the processor and fill with the proper 
reagent to just below the maximum fill line. 
  
 Station #1- 10% buffered formalin 
 Station #2- Deionized water 
 Station #3- 70% Ethanol 
 Station #4- 95% Ethanol 
 Station #5- 95% Ethanol 
 Station #6- 100% Ethanol 
 Station #7- 100% Ethanol 
 Station #8- 50:50 Xylene:100% Ethanol 
 Station #9-  Xylene 
 Station#10- Xylene 
 Station#11- Paraffin 
 Station#12- Paraffin 
 
Standard tissue processing schedule: 16.5hrs 
1. Station   #1- 4 hrs. 
2.          #2- 1.5 hrs. 
3. Stations #3 thru #10- 1hr. each. 
4. Stations #11 and #12 –1.5 hrs.each. 
 
Starting a run: 
1. Open the plexi-glass enclosure. 
2. Press ↑ to elevate the reagent covers. 
3. Add tissue cassettes to the metal basket. 
4. Slide basket into the holder at Station #1. 
5. Press ↓ to lower the basket. 
6. Run #1 is the standard tissue processing run ~16.5hrs. 
7. Press Start/Prog/Start/Prog. 
8. Close the plexi-glass enclosure. 
 
To Stop or Abort a run: 
1. Press Stop button. 
2. Press Start button to resume the run. 
 
 
End of a processing run: 
1. The display will read “Done”  - a beep will sound every 30secs. 
2. Open the plexi-glass enclosure. 
3. Press Stop to end the run. 
4. Press ↑ to elevate the basket. 
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5. To prevent paraffin from dripping on the floor, hold the basket in 
paper towels while transferring samples from the processor to the 
embedding station. 
6. Quickly wipe the excess paraffin from the basket before it hardens. 
7. Press ↓ to lower the reagent covers on the processor. 
8. Close the plexi-glass enclosure.  
 
Procedural Notes: 
Refer to the Leica TP1020 Instruction Manual for more details. 
Refer to the Programming Section of the above manual to program runs. 
 
Reference Procedures: 
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Purpose 
To automatically stain tissue sections with the standard hematoxylin and eosin [H&E] 
stain. 
Hazards 
4. Xylene is a moderate skin and eye irritant; toxic by ingestion, inhalation and skin 
contact. 
 Repeated exposure produces neurotoxic effects, impaired memory, mood swings 
and nerve  damage. Wear viton or teflon gloves, a long-sleeved lab coat and goggles 
when dispensing.  
5. Ethanol is a moderate to severe skin irritant and moderate eye irritant; toxic by 
ingestion producing behavioral and gastrointestinal symptoms. Wear nitrile 
gloves, a long-sleeved lab coat and goggles when dispensing. 
6. Hematoxylin [basic dye] is an equivocal tumorigenic agent in rats after ingestion 
of large quantities. Wear nitrile gloves, a long-sleeved lab coat and goggles when 
dispensing. 
7. Eosin Y [acid dye] has been determined to be an equivocal tumorigenic agent. 
Wear nitrile gloves, a long-sleeved lab coat and goggles when dispensing. 
8. Acid alcohol reagent is 1% concentrated hydrochloric acid in 70% ethanol. – 
wear nitrile gloves, a long-sleeved lab coat and goggles when dispensing. 
Specimen 
Tissue specimen mounted on a glass slide.  
Material Required 
1. Xylene 
2. Ethanol 70%, 95% and 100% 
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3. Hematoxylin stain [Instant]- Thermo-Shandon 
4. Eosin Y stain [Instant] – Thermo-Shandon 
5. 1% Acid alcohol 
6. Ammonium water 






1.  Fill stations with the following reagents: 
a)  Step #1   Station #1- Xylene                    Time: 1.00min 
b)  Step #2               #2- Xylene                               1.00 
c)  Step #3               #3-  100% Ethanol                   1.00 
d)  Step #4               #4-  95% Ethanol                     1.00 
e)  Step #5               #5-  70% Ethanol                     1.00 
f)  Step #6               Wash #1                                  1.00 
g)  Step #7               #6-  Hematoxylin                     10.00 
h)  Step #8               Wash #2                                  1.00 
i)  Step #9               #7-  Acid Alcohol                      .05sec 
j)  Step #10             Wash #3                                  1.00 
k)  Step #11             #8-  Ammonia water                2.00 
l)  Step #12             Wash #4                                  1.00 
m)  Step #13             #9-  Deionized water               1.00 
n)  Step #14     #10- 95% Ethanol                    1.00 
o)  Step #15     #11- Eosin                                5.00 
p)  Step #16     #12- 95% Ethanol                     .30sec 
q)  Step #17     #13- 95% Ethanol                    1.00 
r)  Step #18            #14- 100% Ethanol                   1.00 
s)  Step #19            #15- 100% Ethanol                   1.00 
t)  Step #20            #16-  Xylene                             1.00 
u)  Step #21            #17-  Xylene                             2.00 
2. Place slides into rack and place rack into LOAD drawer. 
3. Select STAIN #1 from the Main Menu 
4. Press LOAD button – light will go off and run will begin. 
5. Close cover. 
6.   When the staining run is done, a beep will sound. 
7.   Press EXIT button- slide open drawer, remove rack. 
8.   Transfer the slide rack to xylene in table top hood. 
9.   Replace reagent covers on stain troughs and close stainer cover. 
Procedural Notes 
Refer to Leica XY Autostainer Guide, 
Keep all solutions at the 400ml level – mid-pt. mark on the trough. 




Change all remaining solutions based on use – approximately every #500 slides. 
Reference Procedures 
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